本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"或"昊华科 技"）第八届董事会第三十二次会议于 2025 年 5 月 28 日以通讯表决 的方式召开。会议通知等材料已于 2025 年 5 月 27 日以电子邮件并短 信通知的方式发送给公司董事、监事、高级管理人员，全体董事一致 同意豁免本次会议通知期限。会议应出席董事 9 名，实际出席董事 9 名，共收回有效表决票 9 份。会议的召开符合相关法律、行政法规、 部门规章、规范性文件和《公司章程》的规定。 会议审议并通过如下议案： 证券代码：600378 证券简称：昊华科技 公告编号：临 2025－048 昊华化工科技集团股份有限公司 第八届董事会第三十二次会议决议公告 一、关于审议聘任龚莉莉女士为公司副总经理的议案 董事会同意聘任龚莉莉女士为公司副总经理，任期自本次董事会 审议通过之日起至公司第八届董事会任期届满之日止。简历附后。 公司董事会提名委员会已审议通过相关议案。 龚莉莉女士与公司的董事、监事、高级管理人员、实际控制人及 持股 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2025－048 董事会同意聘任龚莉莉女士为公司副总经理，任期自本次董事会 审议通过之日起至公司第八届董事会任期届满之日止。简历附后。 昊华化工科技集团股份有限公司 第八届董事会第三十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"或"昊华科 技"）第八届董事会第三十二次会议于 2025 年 5 月 28 日以通讯表决 的方式召开。会议通知等材料已于 2025 年 5 月 27 日以电子邮件并短 信通知的方式发送给公司董事、监事、高级管理人员，全体董事一致 同意豁免本次会议通知期限。会议应出席董事 9 名，实际出席董事 9 名，共收回有效表决票 9 份。会议的召开符合相关法律、行政法规、 部门规章、规范性文件和《公司章程》的规定。 公司董事会提名委员会已审议通过相关议案。 表决结果：9 票同意，0 票反对，0 票弃权。 附件：龚莉莉女士简历 龚莉莉，女，1973 年 10 月出生，汉族，中共党员，正高级工程 ...

Group 1 - The A-share directed issuance market has been active this year, with public institutions participating significantly, investing nearly 10 billion yuan [1] - As of May 21, 21 public institutions participated in 31 A-share companies' directed issuances, with a total subscription amount reaching 9.785 billion yuan, resulting in a floating profit of 1.647 billion yuan and an overall floating profit rate of 16.84% [3] - Among the 21 public institutions involved, 18 achieved a floating profit, representing 85.71% of the participants [3] Group 2 - The competition for quality targets among public institutions shows a "head concentration" characteristic, with 23 out of 31 stocks having public issuance allocations exceeding 100 million yuan [3] - Haohua Technology topped the list with a public issuance allocation of 1.628 billion yuan, attracting three institutions: Caitong Fund, Dacheng Fund, and Nord Fund [3] - Other notable stocks with public issuance allocations exceeding 500 million yuan include Guolian Minsheng, Dize Pharmaceutical, Anning Co., Zhongtung High-tech, Baiwei Storage, and COSCO Shipping Special [3] Group 3 - Among the 31 stocks, 27 achieved floating profits, accounting for 87.10% [4] - Leshan Power led with a floating profit rate of 205.79%, with three public institutions collectively allocated 104 million yuan and a floating profit amounting to 213 million yuan [4]

证券代码：600378 证券简称：昊华科技 公告编号：2025-047 昊华化工科技集团股份有限公司 2024年年度股东大会决议公告 的本次股东大会由公司董事会召集，董事长王军先生主持,采用现场投票和网络 投票相结合的表决方式进行。会议的召集和召开程序、出席会议人员的资格、会 议的表决方式和程序均符合《公司法》及《公司章程》的规定。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 5 月 22 日 (二)股东大会召开的地点：北京市朝阳区小营路 19 号财富嘉园 A 座昊华大厦 19 层会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 309 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 1,091,732,629 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | ...

关于昊华化工科技集团股份有限公司 2024 年年度股东大会的 法律意见书 北京市通商律师事务所 二〇二五年五月 中国北京市建国门外大街 1 号国贸写字楼 2 座 12-15 层 100004 12-15th Floor, China World Office 2, No.1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于昊华化工科技集团股份有限公司 2024 年年度股东大会的 法律意见书 致：昊华化工科技集团股份有限公司 根据《中华人民共和国律师法》《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》《上市公司股东会规则》（以下简称"《股 东会规则》"）、《上海证券交易所上市公司自律监管指引第 1 号——规范运作》 （以下简称"《规范运作指引》"）等法律、法规和规范性文件以及《昊华化工 科技集团股份有限公 ...

Core Viewpoint - The fluorochemical industry in China has achieved significant growth, with the market size projected to increase from 58.85 billion yuan in 2022 to 91.58 billion yuan in 2024, indicating strong overall market demand and rising product value [1][7]. Group 1: Overview of Fluorinated New Materials - Fluorinated new materials are organic polymer compounds formed by replacing hydrogen atoms in the main or side chains with fluorine atoms, resulting in polymers with excellent properties such as high-temperature resistance, chemical corrosion resistance, and low flammability [2][4]. - These materials are increasingly important in various industries, including defense, aerospace, automotive, and electronics, due to their unique characteristics [2][4]. Group 2: Industry Chain of Fluorinated New Materials - The industry chain for fluorinated new materials includes raw materials like fluorite and sulfuric acid, with hydrogen fluoride as a basic product. These materials are crucial for high-end manufacturing, environmental protection, and new energy sectors [9]. - The rapid development of fluorinated new materials is driven by their applications in solar energy, lithium-ion batteries, and fuel cells, leading to an expanding market space and promising future prospects [9]. Group 3: Upstream Raw Materials - China is a major producer of fluorite, with an estimated production of 6.3 million tons in 2023, accounting for approximately 70% of global output. The consumption structure shows that fluorochemical applications dominate, representing over 50% of fluorite usage [11]. Group 4: Downstream Application Areas - In the lithium-ion battery sector, the total production is expected to reach 1170 GWh in 2024, with a year-on-year growth of 24%. Fluorinated materials like lithium hexafluorophosphate and PVDF are essential for battery components [15][17]. - The photovoltaic sector is also growing, with new installed capacity projected at 277.57 GW in 2024, making it the second-largest power source in China. Fluorinated materials such as PVDF and PVF are widely used in solar panel backings [22][24]. Group 5: Policy Support for Fluorinated New Materials - Various local governments in China are implementing policies to support the development of fluorinated new materials, aiming to enhance the overall self-sufficiency of chemical new materials and promote high-end applications [6][13]. Group 6: Future Trends - The fluorinated new materials market is expected to continue expanding due to ongoing developments in downstream applications and increased R&D efforts, leading to technological breakthroughs and broader product applications [30].

今年以来，A股定向增发(以下简称"定增")市场活跃度显著提升，公募机构作为重要参与者，以近百亿 元资金规模深度布局，截至5月21日收盘，整体浮盈率超16%，逾八成公募机构实现正向收益。 财通基金管理有限公司(以下简称"财通基金")相关人士在接受《证券日报》记者采访时表示，在政策推 动下，保险资管、银行理财与公募基金同步参与定增，越来越多的机构参与也将为定增投资者带来多样 化、专业化投资策略，有利于投资者通过此类专业产品和策略，在政策与产业共振中捕捉结构性机会。 18家公募机构实现浮盈 2025年定增市场活跃度提升，与监管部门持续释放的政策红利密切相关。去年发布的"并购六条"明确鼓 励上市公司综合运用股份、定向可转债、现金等支付工具实施并购重组。与此同时，《关于推动中长期 资金入市工作的实施方案》进一步打通中长期资金入市卡点堵点，"允许公募基金、商业保险资金、基 本养老保险基金、企(职)业年金基金、银行理财等作为战略投资者参与上市公司定增"。在业内人士看 来，这使得公募机构与上述机构实现"同权参与"，形成多元化资金供给格局。 "政策端对定增市场的支持体现在两个维度：一是通过并购重组规则优化，提升定增标的的战略价 ...

Group 1 - The new consumption sector in A-shares is gaining significant attention, with multiple brokerages hosting themed strategy meetings, indicating strong market interest [1] - Recent trends show a rise in popularity for industries such as pet products, snacks, health supplements, and beauty care, attracting analysts from other sectors like new energy and technology [1] - The increasing focus on the new consumption trend is likely to influence stock price volatility and enhance overall market activity in the consumption sector [1] Group 2 - The North Exchange 50 Index has reached a historical high, reflecting strong market confidence, with several thematic funds achieving returns exceeding 70% this year [2] - The performance of North Exchange funds has been bolstered by individual stock selection strategies, with many funds successfully identifying stocks that have doubled in value [2] - Industry experts suggest that the weight stocks and new stocks on the North Exchange still hold investment value, indicating potential mid- to long-term investment opportunities [2] Group 3 - Public funds have invested nearly 10 billion yuan in private placements this year, demonstrating confidence in certain A-share companies [3] - Among the stocks favored by public funds, Haohua Technology received significant attention, with multiple funds participating in its private placement, totaling over 1.6 billion yuan [3] - Other companies like Guolian Minsheng, Dizhe Pharmaceutical, and Anning Co. also attracted substantial investment from public funds, each exceeding 500 million yuan [3] Group 4 - In a low-interest-rate environment, private equity strategies are shifting towards equity assets, with a preference for Hong Kong internet and dividend-paying stocks [4] - The difficulty of bond investments has increased, making equity assets more attractive, especially with ongoing policy support and increased stock buybacks [4] - Companies benefiting from AI development and those with high dividend yields are highlighted as worthy of attention, potentially driving capital inflows into these sectors [4]

Group 1 - The company held a performance briefing for the fiscal year 2024 and the first quarter of 2025 on May 20, 2025, via a video and interactive format [1] - In 2024, the company achieved an operating income of 13.966 billion yuan and a net profit of 1.105 billion yuan, ranking among the top in the fluorochemical industry [1][2] - For the first quarter of 2025, the company reported an operating income of 3.157 billion yuan, a year-on-year increase of 10.96%, and a net profit of 214 million yuan, up 21.65% year-on-year [2] Group 2 - The company emphasizes technological innovation as a key driver for future profit growth, supported by a strong R&D foundation and a network of national-level research institutes [2][3] - The chemical industry is expected to recover and maintain moderate growth, driven by improved supply-demand dynamics, policy support, and technological advancements [3][4] - The company has a strong position in high-end fluorochemicals, advanced manufacturing chemical materials, electronic chemicals, and engineering technical services, with significant research and transformation capabilities [4] Group 3 - The company is actively managing its market value and has established a value management system to enhance investor confidence and reflect the company's true value [5] - The average sales price of fluorocarbon chemicals in the first quarter of 2025 was 42,800 yuan per ton, with a quarter-on-quarter increase of 40.05% and a year-on-year increase of 49.27% [6] - The subsidiary, Zhonghua Lantian, achieved an operating income of 666.022 million yuan and a net profit of 45.561 million yuan in 2024, exceeding its annual performance commitments [6]

证券代码：600378 证券简称：昊华科技 公告编号：临 2025-046 昊华化工科技集团股份有限公司 关于 2024 年度暨 2025 年第一季度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担法律责任。 一、本次说明会召开情况 昊华化工科技集团股份有限公司（以下简称"公司"） 2024 年度暨 2025 年第 一季度业绩说明会于 2025 年 5 月 20 日（星期二）下午 15:00-16:00，通过上海证 券交易所上证路演中心以视频结合网络互动形式召开。公司董事长、总经理王军 先生，独立董事李姝女士，财务总监、首席合规官、总法律顾问何捷先生及董事 会秘书苏静祎女士参加了说明会，并在信息披露允许的范围内就投资者关注的事 项与投资者进行了交流与沟通。 公司已于 2025 年 4 月 30 日在上海证券交易所网站（www.sse.com.cn）及《中 国证券报》《上海证券报》《证券时报》披露了《昊华科技关于召开 2024 年度暨 2025 年第一季度业绩说明会的公告》（公告编号：临 2025－043）。 二、 ...